TIL Engineered With Membrane-Binding Cytokine
1 clinical trials · Condition
◉ Watch TIL Engineered With Membrane-Binding Cytokine
| Record | Firm | Date |
|---|---|---|
| A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital) (NCT05468307) | Shanghai Juncell Therapeutics | 2022-03-10 |
Track TIL Engineered With Membrane-Binding Cytokine automatically
Every clearance here is in the API, with alerts when new ones post.